lintuzumab
... that Seattle Genetics withdrew its drug lintuzumab as a treatment for acute myeloid leukemia in September 2010 after a clinical study found that it offered no greater benefit than placebo therapy?
... that Seattle Genetics withdrew its drug <b id="mwB4A"><a href="./Lintuzumab" id="mwB4E" rel="mw:WikiLink" title="Lintuzumab">lintuzumab</a></b> as a treatment for <a href="./Acute_myeloid_leukemia" id="mwB4I" rel="mw:WikiLink" title="Acute myeloid leukemia">acute myeloid leukemia</a> in <span about="#mwt42" class="nowrap" data-mw='{"parts":[{"template":{"target":{"wt":"Nowrap","href":"./Template:Nowrap"},"params":{"1":{"wt":"September 2010"}},"i":0}}]}' id="mwB4M" typeof="mw:Transclusion">September 2010</span> after a <a class="mw-redirect" href="./Clinical_study" id="mwB4Q" rel="mw:WikiLink" title="Clinical study">clinical study</a> found that it offered no greater benefit than <a href="./Placebo" id="mwB4U" rel="mw:WikiLink" title="Placebo">placebo</a> therapy?